Shen Yongchun, Huang Shaoguang, Kang Jian, Lin Jiangtao, Lai Kefang, Sun Yongchang, Xiao Wei, Yang Lan, Yao Wanzhen, Cai Shaoxi, Huang Kewu, Wen Fuqiang
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu.
Department of Pulmonary Disease, Ruijin Hospital, Shanghai Jiao Tong University, Shanghai.
Int J Chron Obstruct Pulmon Dis. 2018 Jan 30;13:399-407. doi: 10.2147/COPD.S144312. eCollection 2018.
Airway mucus hypersecretion is one of the most important characteristics of chronic airway inflammatory diseases. Evaluating and managing airway mucus hypersecretion is of great importance for patients with chronic airway inflammatory diseases. This consensus statement describes the pathogenesis, clinical features, and the management of airway mucus hypersecretion in patients with chronic airway inflammatory diseases in the People's Republic of China. The statement has been written particularly for respiratory researchers, pulmonary physicians, and patients.
气道黏液高分泌是慢性气道炎症性疾病最重要的特征之一。评估和管理气道黏液高分泌对慢性气道炎症性疾病患者至关重要。本共识声明描述了中华人民共和国慢性气道炎症性疾病患者气道黏液高分泌的发病机制、临床特征及管理。该声明是专门为呼吸研究人员、肺科医生和患者撰写的。
